Seasoned private markets executive focused on growth-stage technology and consumer investments, with operating experience in scaling revenue and go-to-market teams. Alan Gilmore is known for blending operational leadership with portfolio oversight, advising CEOs on strategic product and commercialization initiatives while leading deal sourcing and due diligence. Typical involvement spans board-level governance, capital strategy and exit preparation for venture and lower-middle market private equity transactions. Market-facing skills include investor relations, LP reporting and cross-border M&A execution.
Seasoned private markets executive focused on growth-stage technology and consumer investments, with operating experience in scaling revenue and go-to-market teams. Alan Gilmore is known for blending operational leadership with portfolio oversight, advising CEOs on strategic product and commercialization initiatives while leading deal sourcing and due diligence. Typical involvement spans board-level governance, capital strategy and exit preparation for venture and lower-middle market private equity transactions. Market-facing skills include investor relations, LP reporting and cross-border M&A execution.
Operates with an operator-investor mindset targeting growth-stage technology and consumer businesses where go-to-market scaling drives value. Prefers active, board-level involvement to align product, commercialization and capital strategy with exit planning, emphasizing revenue growth, unit economics and repeatable sales motion. Underwrites opportunities through operational due diligence, founder alignment and measurable GTM milestones, allocating capital for revenue acceleration rather than financial engineering. Time horizon is multi-year growth-to-exit, with disciplined risk controls and cross-border M&A optionality.
Operates with an operator-investor mindset targeting growth-stage technology and consumer businesses where go-to-market scaling drives value. Prefers active, board-level involvement to align product, commercialization and capital strategy with exit planning, emphasizing revenue growth, unit economics and repeatable sales motion. Underwrites opportunities through operational due diligence, founder alignment and measurable GTM milestones, allocating capital for revenue acceleration rather than financial engineering. Time horizon is multi-year growth-to-exit, with disciplined risk controls and cross-border M&A optionality.
| Trades 7265 | Longs Won 3915/7265 53% | Profit Factor 32.92 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $207,750.76 |
| Average Win $26,694.41 | Best Trade (Jul 13) $12M | Sharpe Ratio -12.47 |
| Average Loss -$947.68 | Worst Trade (Jul 14) -$510,890.98 | Z-Score 6.21 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 2w 1d | Expectancy $13,945.92 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 500,000 | 450,000 | 400,000 | 350,000 | 300,000 | 250,000 | 200,000 | 150,000 | 100,000 | 50,000 |